全文获取类型
收费全文 | 121篇 |
免费 | 10篇 |
专业分类
儿科学 | 2篇 |
妇产科学 | 2篇 |
基础医学 | 31篇 |
口腔科学 | 2篇 |
临床医学 | 17篇 |
内科学 | 41篇 |
皮肤病学 | 3篇 |
神经病学 | 12篇 |
外科学 | 1篇 |
预防医学 | 6篇 |
眼科学 | 1篇 |
药学 | 5篇 |
肿瘤学 | 8篇 |
出版年
2023年 | 3篇 |
2022年 | 2篇 |
2021年 | 12篇 |
2019年 | 3篇 |
2018年 | 6篇 |
2017年 | 1篇 |
2016年 | 3篇 |
2015年 | 8篇 |
2014年 | 4篇 |
2013年 | 8篇 |
2012年 | 10篇 |
2011年 | 17篇 |
2010年 | 5篇 |
2009年 | 2篇 |
2008年 | 8篇 |
2007年 | 5篇 |
2006年 | 6篇 |
2005年 | 3篇 |
2004年 | 7篇 |
2003年 | 1篇 |
2002年 | 1篇 |
1998年 | 1篇 |
1996年 | 2篇 |
1995年 | 1篇 |
1994年 | 1篇 |
1992年 | 2篇 |
1991年 | 1篇 |
1990年 | 2篇 |
1986年 | 1篇 |
1984年 | 1篇 |
1970年 | 2篇 |
1967年 | 1篇 |
1948年 | 1篇 |
排序方式: 共有131条查询结果,搜索用时 15 毫秒
1.
B Flott-Rahmel W Gerdes P A Pechan W Brysch K H Schlingensiepen W Seifert 《Neuroreport》1992,3(12):1077-1080
Basic FGF mRNA induction by bFGF was investigated in cell cultures from rat brain, i.e. postnatal day 2 cortex and embryonic day 18 hippocampus. In situ hybridization shows that after bFGF treatment (10(-10) M) for 14 h neurones and glial cells show a remarkable increase in bFGF mRNA production. Incubation of astrocytes with antisense bFGF phosphorothioate oligodeoxynucleotides (bFGF-PTOs) resulted in an inhibition of both bFGF induced and serum induced proliferation. The results indicate that bFGF is capable of inducing its own mRNA production. This induction, i.e. new synthesis of bFGF mRNA, seems to be essential for the mitogenic effect of both bFGF and serum components. 相似文献
2.
Uwe-Martin Zurmöhle Jochen Herms Reimar Schlingensiepen Karl-Hermann Schlingensiepen Wolfgang Brysch 《Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale》1994,99(1):17-24
Synapsin I is a synaptic phosphoprotein that is involved in the short-term regulation of neurotransmitter release. In this report we present the first extensive study of the developmental expression of its corresponding messenger ribonucleic acid (mRNA) by in situ hybridization and northern blot analysis in rat brain. Synapsin I mRNA showed pronounced differences in expression in different brain regions during postnatal development. The early expression of synapsin I mRNA in ontogenetically older regions such as the thalamus, the piriform cortex and the hippocampus coincides with the earlier maturation of these regions, in contrast to its later expression in ontogenetically younger areas such as the cerebellum and the neocortex. An intriguing expression pattern was found in the hippocampus. In all hippocampal subregions synapsin I mRNA expression increased from postnatal day (PND) 1 to 17. After PND 17, however, there was a marked dissociation between persisting high expression levels in CA3 and the dentate gyrus and a strong decline in synapsin I mRNA expression in CA1. The persistence of synapsin I in some adult rat brain regions indicates that it plays a part in synapse formation during plastic adaption in neuronal connectivities. 相似文献
3.
4.
Johne Reimar Althof Nadine Nöckler Karsten Falkenhagen Alexander 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2022,65(2):202-208
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Das Hepatitis-E-Virus (HEV) ist ein Erreger einer akuten Hepatitis beim Menschen. Darüber hinaus treten zunehmend auch... 相似文献
5.
M. Magerl M. Rother T. Bieber T. Biedermann J. Brasch R. Dominicus N. Hunzelmann T. Jakob V. Mahler G. Popp K. Schäkel R. Schlingensiepen J. Schmitt F. Siebenhaar J.C. Simon P. Staubach B. Wedi C. Weidner M. Maurer 《Journal of the European Academy of Dermatology and Venereology》2013,27(3):e363-e369
Background Chronic spontaneous urticaria (CSU), a mast cell‐driven condition, is debilitating, common, and hard to treat. Miltefosine, a lipid raft modulator, can inhibit mast cell responses in vivo. Objective To study the safety and efficacy of systemic miltefosine treatment in CSU patients resistant to standard‐dosed antihistamines. Methods In this investigator‐initiated multicentre, randomized, double‐blind, placebo‐controlled study, CSU patients were treated for 4 weeks with daily doses of up to 150‐mg miltefosine (n = 47) or placebo (n = 26). Disease activity was assessed using the urticaria activity score. Safety and tolerability of miltefosine were also assessed. Results After 4 weeks of treatment, Urticaria Activity Score (UAS7) levels were substantially more reduced in miltefosine‐treated patients (?6.3 vs. ?3.5 in placebo‐treated patients; P = 0.05). Also, the number of weals, but not the intensity of pruritus, was significantly reduced in miltefosine‐treated patients vs. placebo‐treated patients (P = 0.02). In general, adverse events were frequent in both groups (miltefosine: 88%, placebo: 65% of patients) but mostly mild to moderate in severity. We did not observe any serious adverse events. Conclusions The results of this study indicate that miltefosine is an effective and safe treatment option for CSU patients who do not respond to standard‐dosed antihistamines. 相似文献
6.
7.
Sandro Wolf Jochen Reetz Reimar Johne Ann-Charlotte Heiberg Samuel Petri Hanna Kanig Rainer G. Ulrich 《Archives of virology》2013,158(7):1575-1578
Wild rats can be reservoirs and vectors for several human pathogens. An initial RT-PCR screening of the intestinal contents of Norway rats trapped in the sewer system of Copenhagen, Denmark, for caliciviruses revealed the presence of a human norovirus in one of 11 rodents. Subsequent phylogenetic analysis of the ~4.0-kb 3′-terminus of the norovirus genome resulted in the identification of a recombinant GI.b/GI.6 strain. The simultaneous detection of hepatitis E virus-like particles in the feces of this rat by transmission electron microscopy was confirmed by RT-PCR and sequence determination, resulting in the identification of a novel rat hepatitis E virus. 相似文献
8.
Mustapha Itani Sandra Sif Gylfadottir Thomas Krigrd Alexander Gramm Kristensen Diana Hedevang Christensen Pall Karlsson Sren Mller Henning Andersen Hatice Tankisi Jens Steen Nielsen Troels Staehelin Jensen Reimar Wernich Thomsen Nanna Brix Finnerup Sren Hein Sindrup 《Journal of the peripheral nervous system : JPNS》2021,26(1):55-65
Diabetic polyneuropathy (DPN) can be classified based on fiber diameter into three subtypes: small fiber neuropathy (SFN), large fiber neuropathy (LFN), and mixed fiber neuropathy (MFN). We examined the effect of different diagnostic models on the frequency of polyneuropathy subtypes in type 2 diabetes patients with DPN. This study was based on patients from the Danish Center for Strategic Research in Type 2 Diabetes cohort. We defined DPN as probable or definite DPN according to the Toronto Consensus Criteria. DPN was then subtyped according to four distinct diagnostic models. A total of 277 diabetes patients (214 with DPN and 63 with no DPN) were included in the study. We found a considerable variation in polyneuropathy subtypes by applying different diagnostic models independent of the degree of certainty of DPN diagnosis. For probable and definite DPN, the frequency of subtypes across diagnostic models varied from: 1.4% to 13.1% for SFN, 9.3% to 21.5% for LFN, 51.4% to 83.2% for MFN, and 0.5% to 14.5% for non‐classifiable neuropathy (NCN). For the definite DPN group, the frequency of subtypes varied from: 1.6% to 13.5% for SFN, 5.6% to 20.6% for LFN, 61.9% to 89.7% for MFN, and 0.0% to 6.3% for NCN. The frequency of polyneuropathy subtypes depends on the type and number of criteria applied in a diagnostic model. Future consensus criteria should clearly define sensory functions to be tested, methods of testing, and how findings should be interpreted for both clinical practice and research purpose. 相似文献
9.
10.
AIMS: To compare immunohistochemical staining for oestrogen receptor, progesterone receptor and HER-2 between core biopsy and matched subsequent excisional specimens. METHODS: One hundred consecutive core biopsy cases and subsequent excisional specimens were retrieved and immunohistochemical staining performed. Proportion and intensity of staining for hormone receptors and HercepTest score were recorded for each case in a blinded fashion by the authors. RESULTS: Overall hormone receptor status was concordant between cores and excisions in 96.9% of cases. ER status was concordant between the core and excision in 95.8% of cases. The intensity of staining for ER was similar in both core and excision specimens. PR status was concordant in cores and excisions in 90.3% of cases. There was weaker PR staining in the excisional specimens when compared with the cores. HER-2 status was concordant in cores and excisions in 86.6% of cases. CONCLUSIONS: Hormone receptor staining produced similar results on core and excisional specimens, although a small number of additional hormone receptor positive cases could be detected by performing staining on a previously received core in the case of a negative result on the excisional specimen. HER-2 staining is less reproducible between cores and excisions, but the clinical significance of this observation remains to be tested. 相似文献